IL-32&#x03B1 suppresses colorectal cancer development via TNFR1-mediated death signaling

Hyung-Mun Yun; Kyung-Ran Park; Eun-Cheol Kim; Sang Bae Han; Do Young Yoon; Jin Tae Hong

doi:10.18632/oncotarget.3197

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling

Hyung-Mun Yun, Kyung-Ran Park, Eun-Cheol Kim, Sang Bae Han, Do Young Yoon _ and Jin Tae Hong

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:9061-9072. https://doi.org/10.18632/oncotarget.3197

Metrics: PDF 2377 views | HTML 2638 views | ?

Abstract

Hyung-Mun Yun1,*, Kyung-Ran Park1,*, Eun-Cheol Kim1, Sang Bae Han2, Do Young Yoon3, Jin Tae Hong2

1Department of Maxillofacial Tissue Regeneration, School of Dentistry and Research Center for Tooth & Periodontal Regeneration (MRC), Kyung Hee University, Seoul 130-701, Republic of Korea

2College of Pharmacy and Medical Research Center, Chungbuk National University, Heungduk-gu, Cheongju, Chungbuk 361-763, Republic of Korea

3Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 150-716, Republic of Korea

*These authors have contributed equally to this work

Correspondence to:

Jin Tae Hong, e-mail: [email protected]

Keywords: IL-32α, colon cancer, TNFR1, RIP1

Received: January 01, 2015 Accepted: January 25, 2015 Published: April 13, 2015

ABSTRACT

Inflammation is associated with cancer-prone microenvironment, leading to cancer. IL-32 is expressed in chronic inflammation-linked human cancers. To investigate IL-32α in inflammation-linked colorectal carcinogenesis, we generated a strain of mice, expressing IL-32 (IL-32α-Tg). In IL-32α-Tg mice, azoxymethane (AOM)-induced colon cancer incidence was decreased, whereas expression of TNFR1 and TNFR1-medicated apoptosis was increased. Also, IL-32α increased ROS production to induce prolonged JNK activation. In colon cancer patients, IL-32α and TNFR1 were increased. These findings indicate that IL-32α suppressed colon cancer development by promoting the death signaling of TNFR1.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3197

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling

Abstract